Why is Heartflow stock surging today?
Investing.com reports Heartflow (HTFL) shares rose 16.1% in after-hours to $36 after its Q2 results beat expectations. Adjusted loss per share was -$0.07 vs -$0.19 consensus. Revenue was $64.1M, up 48% YoY. Full-year 2026 revenue guidance was raised to $246M-$250M. CEO John Farquhar sold 22,562 shares under a Rule 10b5-1 plan.
How this was made
The 30-second read
Why it matters
HTFL’s after-hours jump is tied to a quantified earnings beat (adjusted loss per share) and a sizable revenue growth rate, plus a raised guidance range that signals stronger commercial traction.
Market read
A quantified earnings and guidance beat is a direct catalyst for HTFL positioning, likely prompting rapid repricing and momentum trading.
What to watch
The article notes a routine 10b5-1 CEO sale; traders may still want to monitor whether any additional competitive developments (e.g., Cleerly litigation) emerge.
Background
The piece frames HTFL’s rally as primarily driven by its Q2 results and an upward revision to full-year 2026 revenue guidance.
Ticker impact
Heartflow (HTFL) surged after-hours on a Q2 earnings beat and raised full-year 2026 revenue guidance to $246M-$250M.
Near-term upside bias with elevated volatility; follow-through depends on whether investors treat the raised range as credible versus prior outlook.
The article cites specific EPS, revenue growth, and a concrete full-year guidance increase, which are direct drivers of valuation and positioning.
Market effects
Positive read-through for AI cardiac diagnostics and medical technology sentiment, though the article provides no new sector-wide policy or trial data.
No meaningful regional spillover described; broader U.S. indices were nearly flat.
No global catalysts mentioned beyond company-specific results.
Counterpoint
The stock’s move may be driven by one quarter’s beat and guidance lift, which could still face execution risk if adoption slows.
Key entities
- companyHeartflow
AI-powered cardiac diagnostics company whose Q2 results and raised 2026 revenue guidance drove the after-hours surge.
- companyCleerly
Competitor mentioned in the context of a prior patent infringement suit, with no new news reported today.
- personJohn Farquhar
CEO who sold shares under a pre-scheduled Rule 10b5-1 plan on August 10.

